Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
6.92
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
7.05
+0.13 (1.88%)
After-hours: Apr 2, 2026, 7:11 PM EDT
Alpha Tau Medical Employees
Alpha Tau Medical had 121 employees as of December 31, 2025. The number of employees decreased by 4 or -3.20% compared to the previous year.
Employees
121
Change (1Y)
-4
Growth (1Y)
-3.20%
Revenue / Employee
n/a
Profits / Employee
-$352,289
Market Cap
609.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 121 | -4 | -3.20% |
| Dec 31, 2024 | 125 | 4 | 3.31% |
| Dec 31, 2023 | 121 | 27 | 28.72% |
| Dec 31, 2022 | 94 | 11 | 13.25% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| ProKidney | 231 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| Ocugen | 116 |
| Aclaris Therapeutics | 73 |
| Tectonic Therapeutic | 60 |
DRTS News
- 4 days ago - Alpha Tau Announces First-Ever Oral Presentation of Alpha DaRT® Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026 - GlobeNewsWire
- 11 days ago - Alpha Tau Medical: 2026 Is The Breakthrough Year - Seeking Alpha
- 19 days ago - Alpha Tau to Present at Sidoti March Virtual Small Cap Conference - GlobeNewsWire
- 26 days ago - Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT - Business Wire
- 5 weeks ago - Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer - GlobeNewsWire
- 2 months ago - Altamirano PLLC Issues Investor Notice on Inspired Healthcare Capital (IHC) Chapter 11 Bankruptcy Filing - GlobeNewsWire
- 2 months ago - Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead - GlobeNewsWire